The awareness for the penny stock of Arch Therapeutics, Inc. (ARTH) has hit a peak (or a desperation point) with dozens of newsletters issuing alerts to end the week. Shares of ARTH stock have had a pretty dismal track record since they peaked at 1.36 just over a month ago. Hoping that surgeons ...
Continue Reading →AUG